Abstract

Human plasma HDLs are classified on the basis of apolipoprotein composition into those that contain apolipoprotein A-I (apoA-I) without apoA-II [(A-I)HDL] and those containing apoA-I and apoA-II [(A-I/A-II)HDL]. ApoA-I enters the plasma as a component of discoidal particles, which are remodeled into spherical (A-I)HDL by LCAT. ApoA-II is secreted into the plasma either in the lipid-free form or as a component of discoidal high density lipoproteins containing apoA-II without apoA-I [(A-II)HDL]. As discoidal (A-II)HDL are poor substrates for LCAT, they are not converted into spherical (A-II)HDL. This study investigates the fate of apoA-II when it enters the plasma. Lipid-free apoA-II and apoA-II-containing discoidal reconstituted HDL [(A-II)rHDL] were injected intravenously into New Zealand White rabbits, a species that is deficient in apoA-II. In both cases, the apoA-II was rapidly and quantitatively incorporated into spherical (A-I)HDL to form spherical (A-I/A-II)HDL. These particles were comparable in size and composition to the (A-I/A-II)HDL in human plasma. Injection of lipid-free apoA-II and discoidal (A-II)rHDL was also accompanied by triglyceride enrichment of the endogenous (A-I)HDL and VLDL as well as the newly formed (A-I/A-II)HDL. We conclude that, irrespective of the form in which apoA-II enters the plasma, it is rapidly incorporated into spherical HDLs that also contain apoA-I to form (A-I/A-II)HDL.

Highlights

  • Human plasma HDLs are classified on the basis of apolipoprotein composition into those that contain apolipoprotein are remodeled into spherical (A-I) without apoA-II [(A-I)HDL] and those containing apolipoprotein A-I (apoA-I) and apoA-II [(A-I/A-II)HDL]

  • The present study investigates the in vivo formation of spherical (A-I/A-II)HDL by injecting human apoA-II in either the lipid-free form or as a component of discoidal (A-II)reconstituted high density lipoprotein (rHDL) into rabbits, a species that is naturally deficient in apoA-II and does not have endogenous (A-I/ A-II)HDL

  • This was achieved by injecting either lipid-free apoA-II or discoidal (A-II)rHDL into rabbits, a species that is naturally deficient in apoA-II and does not have endogenous (A-I/ A-II)HDL

Read more

Summary

Introduction

Human plasma HDLs are classified on the basis of apolipoprotein composition into those that contain apolipoprotein A-I (apoA-I) without apoA-II [(A-I)HDL] and those containing apoA-I and apoA-II [(A-I/A-II)HDL]. Discoidal (A-I)HDL are assembled in the plasma when phospholipids and unesterified cholesterol from cell membranes, or from triglyceride-rich lipoproteins that are undergoing lipolysis, associate with lipid-free or lipid-poor apoA-I. Irrespective of their origins, discoidal (A-I)HDL are excellent substrates for LCAT [9]. ApoA-II is a hydrophobic apolipoprotein that is synthesized in the liver [10] It is unclear whether apoA-II enters the plasma as a component of discoidal (A-II)HDL or whether it associates with phospholipids and unesterified cholesterol to form discoidal particles after it is secreted [11]. It is surprising that most of the apoA-II in human plasma is present as a component

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call